Philips and Medtronic advocacy partnership aims to help accelerate access to life-saving treatments 24-10-2024, 20:00

Bitget's Liquidity Depth Analysis Highlights Competitive Edge in Crypto Trading 20-02-2025, 17:44

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal 10-07-2024, 07:00